Metastatic Breast Cancer Treatment Market 2017-2019 - Global Industry Analysis, Trends, Market Size, and Forecasts to 2025 - ResearchAndMarkets.com

DUBLIN--()--The "Metastatic Breast Cancer Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025" report has been added to ResearchAndMarkets.com's offering.

The report predicts the global metastatic breast cancer treatment market to grow with a CAGR of 9.6% over the forecast period from 2019-2025.

The report on the global metastatic breast cancer treatment market provides qualitative and quantitative analysis for the period from 2017 to 2025. The study on metastatic breast cancer treatment market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on metastatic breast cancer treatment market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global metastatic breast cancer treatment market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global metastatic breast cancer treatment market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

  • Increasing consumption of tobacco and alcohol
  • Exposure to ionizing and ultraviolet radiation

2) Restraints

  • The high cost of the treatment and several side effects associated with drugs

3) Opportunities

  • Improving access to affordable care via health care reform

Key Topics Covered:

1. Preface

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

2. Executive Summary

2.1. Metastatic Breast Cancer Treatment Market Highlights

2.2. Metastatic Breast Cancer Treatment Market Projection

2.3. Metastatic Breast Cancer Treatment Market Regional Highlights

3. Global Metastatic Breast Cancer Treatment Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. Porter's Five Forces Analysis

3.4. Growth Matrix Analysis

3.4.1. Growth Matrix Analysis by Treatment Type

3.4.2. Growth Matrix Analysis by End User

3.4.3. Growth Matrix Analysis by Region

3.5. Value Chain Analysis of Metastatic Breast Cancer Treatment Market

4. Metastatic Breast Cancer Treatment Market Macro Indicator Analysis

5. Global Metastatic Breast Cancer Treatment Market by Treatment Type

5.1. Chemotherapy

5.2. Radiation Therapy

5.3. Biologic Targeted Therapy

5.4. Breast Surgery

5.5. Hormone Therapy

6. Global Metastatic Breast Cancer Treatment Market by End User

6.1. Hospitals

6.2. Clinics

6.3. Other Users

7. Global Metastatic Breast Cancer Treatment Market by Region 2019-2025

7.1. North America

7.1.1. North America Metastatic Breast Cancer Treatment Market by Treatment Type

7.1.2. North America Metastatic Breast Cancer Treatment Market by End User

7.1.3. North America Metastatic Breast Cancer Treatment Market by Country

7.2. Europe

7.3. Asia-Pacific

7.4. RoW

8. Company Profiles and Competitive Landscape

8.1. Competitive Landscape in the Global Metastatic Breast Cancer Treatment Market

8.2. Companies Profiles

8.2.1. F. Hoffmann-La Roche AG

8.2.2. Pfizer Inc.

8.2.3. Novartis AG

8.2.4. Merck & Co., Inc.

8.2.5. Eli Lilly and Company

8.2.6. GlaxoSmithKline plc

8.2.7. Johnson and Johnson

8.2.8. AstraZeneca plc

8.2.9. Bayer AG

8.2.10. Sun Pharmaceutical Industries Ltd

For more information about this report visit https://www.researchandmarkets.com/r/fhuwi9

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Breast Cancer Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Breast Cancer Drugs